Raymond James Financial Inc. Takes $3.75 Million Position in Crescent Capital BDC, Inc. (NASDAQ:CCAP)

Raymond James Financial Inc. purchased a new position in Crescent Capital BDC, Inc. (NASDAQ:CCAP - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 195,130 shares of the company's stock, valued at approximately $3,750,000. Raymond James Financial Inc. owned 0.53% of Crescent Capital BDC as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Montag A & Associates Inc. bought a new position in Crescent Capital BDC in the fourth quarter worth approximately $35,000. Oppenheimer & Co. Inc. purchased a new position in shares of Crescent Capital BDC in the 4th quarter valued at $261,000. Ieq Capital LLC raised its position in shares of Crescent Capital BDC by 2.6% in the 4th quarter. Ieq Capital LLC now owns 22,725 shares of the company's stock worth $437,000 after acquiring an additional 584 shares in the last quarter. Redhawk Wealth Advisors Inc. purchased a new stake in shares of Crescent Capital BDC during the 4th quarter worth $659,000. Finally, Van ECK Associates Corp lifted its stake in shares of Crescent Capital BDC by 2.3% during the 4th quarter. Van ECK Associates Corp now owns 45,562 shares of the company's stock worth $876,000 after purchasing an additional 1,006 shares during the last quarter. 49.46% of the stock is currently owned by institutional investors.

Crescent Capital BDC Stock Down 1.5 %

Shares of CCAP traded down $0.27 during midday trading on Friday, hitting $17.52. 113,525 shares of the company's stock traded hands, compared to its average volume of 135,252. The company has a current ratio of 1.32, a quick ratio of 1.26 and a debt-to-equity ratio of 1.18. The stock has a market capitalization of $649.33 million, a price-to-earnings ratio of 8.80 and a beta of 0.82. Crescent Capital BDC, Inc. has a 1 year low of $16.81 and a 1 year high of $20.19. The firm's fifty day moving average is $18.60 and its 200-day moving average is $18.79.

Remove Ads

Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) last released its quarterly earnings results on Wednesday, February 19th. The company reported $0.55 EPS for the quarter, missing analysts' consensus estimates of $0.56 by ($0.01). Crescent Capital BDC had a net margin of 37.32% and a return on equity of 11.90%. The business had revenue of $46.40 million during the quarter, compared to analysts' expectations of $47.27 million. As a group, sell-side analysts anticipate that Crescent Capital BDC, Inc. will post 2.09 earnings per share for the current year.

Crescent Capital BDC Dividend Announcement

The business also recently announced a dividend, which was paid on Friday, March 14th. Investors of record on Friday, February 28th were paid a $0.05 dividend. The ex-dividend date was Friday, February 28th. Crescent Capital BDC's dividend payout ratio (DPR) is presently 84.42%.

Analyst Upgrades and Downgrades

Separately, Wells Fargo & Company cut their target price on Crescent Capital BDC from $19.00 to $18.00 and set an "equal weight" rating on the stock in a research note on Friday, February 21st. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $19.20.

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.